Intech Investment Management LLC Has $2.94 Million Stock Holdings in Omega Healthcare Investors, Inc. $OHI

Key Points

• Intech Investment Management LLC increased its stake in Omega Healthcare Investors, Inc. by 58.2%, holding $2.94 million worth of shares as of its latest SEC filing.
• Analyst ratings for Omega Healthcare Investors range from Buy to Hold, with a consensus rating of "Moderate Buy" and an average target price of $43.75.
• The company declared a quarterly dividend of $0.67, reflecting a 6.3% yield with a high dividend payout ratio of 165.43%.

Intech Investment Management LLC increased its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 58.2% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 77,107 shares of the real estate investment trust's stock after purchasing an additional 28,364 shares during the quarter. Intech Investment Management LLC's holdings in Omega Healthcare Investors were worth $2,936,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of OHI. NBC Securities Inc. acquired a new stake in shares of Omega Healthcare Investors in the first quarter valued at approximately $29,000. Park Square Financial Group LLC bought a new position in Omega Healthcare Investors during the fourth quarter worth $61,000. UMB Bank n.a. increased its holdings in shares of Omega Healthcare Investors by 94.9% in the first quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares during the last quarter. Meeder Asset Management Inc. increased its holdings in shares of Omega Healthcare Investors by 1,581.3% in the first quarter. Meeder Asset Management Inc. now owns 2,522 shares of the real estate investment trust's stock valued at $96,000 after purchasing an additional 2,372 shares during the last quarter. Finally, Virtus Investment Advisers Inc. bought a new position in shares of Omega Healthcare Investors in the fourth quarter valued at about $112,000. Institutional investors own 65.25% of the company's stock.

Analyst Ratings Changes

Several analysts recently commented on the stock. Mizuho lifted their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a report on Thursday. Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $41.00 to $44.00 and gave the stock an "overweight" rating in a report on Wednesday, August 27th. Royal Bank Of Canada increased their target price on Omega Healthcare Investors from $39.00 to $41.00 and gave the stock a "sector perform" rating in a research note on Thursday, August 7th. Raymond James Financial reissued an "outperform" rating on shares of Omega Healthcare Investors in a report on Tuesday, September 2nd. Finally, Scotiabank upped their price objective on Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a report on Thursday, August 28th. Five analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Omega Healthcare Investors currently has a consensus rating of "Moderate Buy" and an average target price of $43.75.

Insider Activity

In other news, Director Lisa Egbuonu-Davis sold 2,500 shares of the firm's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director owned 18,654 shares of the company's stock, valued at approximately $749,144.64. This trade represents a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.50% of the company's stock.

Omega Healthcare Investors Price Performance

Shares of OHI opened at $42.49 on Monday. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. The stock has a market cap of $12.53 billion, a PE ratio of 26.23, a PEG ratio of 2.22 and a beta of 0.71. Omega Healthcare Investors, Inc. has a 12-month low of $35.04 and a 12-month high of $44.42. The business has a 50-day simple moving average of $40.26 and a two-hundred day simple moving average of $38.25.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a return on equity of 9.78% and a net margin of 42.23%.The company had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. During the same period in the previous year, the business posted $0.71 earnings per share. The business's quarterly revenue was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. Analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.3%. The ex-dividend date was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is 165.43%.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.